Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
AI in Pharmacovigilance: Key Takeaways from Boehringer Ingelheim’s Recent Rollout
In conversation with Pharmaceutical Outsourcing, Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, reflect on some of the lessons learned from Boehringer’s deployment of AI to date in targeted use cases, starting with adverse event case intake and processing. read more
Hasty Decisions, Runaway Projects
Despite the best intentions of ISO and EMA, the pharma industry is still largely failing to exploit its data in a strategic, joined-up way - and this could now restrict companies’ ability to capitalize on AI. read more
An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Orphan Therapeutics Accelerator Adds CDMO and Access Partners to Ultra-Rare Disease Network
Thursday, June 25, 2026
Orphan Therapeutics Accelerator has expanded its Orphan ClinDevNet development network with four new strategic partners—OPIS, Uniphar, SK pharmteco ... read more
Celerion Expands Zurich Bioanalytical Laboratory
Thursday, June 25, 2026
Celerion announced the expansion of its bioanalytical laboratory in Zurich, Switzerland. The investment strengthens Celerion’s ability to support ... read more
Shilpa Biologicals Commissions Integrated ADC Drug Substance GMP Manufacturing Facility
Thursday, June 25, 2026
Shilpa Biologicals announced the commissioning of a state-of-the-art Antibody–Drug Conjugate (ADC) GMP manufacturing facility, purpose-built and ... read more
WuXi Biologics’ 25th Drug Substance Plant Completes First GMP Run with No Deviations
Thursday, June 25, 2026
WuXi Biologics said its MFG17 drug substance facility at the Shanghai Fengxian site has successfully completed its first GMP production campaign, with... read more
Sanner Unifies Global Operations Under Single Brand
Tuesday, June 23, 2026
Sanner is rebranding its subsidiaries under a single Sanner Group umbrella, beginning with the transition of UK-based Springboard to Sanner UK. read more